论文部分内容阅读
统计了1994～1997年舒普深、菌必治在医院的应用数量和费用，并与国产头孢拉定注射液对比，分析了PDD值、增长指数等主要指标。结果显示，近年来舒普深和菌秘治在我院的应用数量呈上升趋势，但增长速度有所不同。
The number and cost of Shu Pushen and Bacterostat in the hospital from 1994 to 1997 were calculated and compared with the domestic cephradine injection. The main indicators such as PDD value and growth index were analyzed. The results show that the number of applications of Shu Pushen and mycosis in our hospital has been increasing in recent years, but the growth rate is different.